-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Share
Listen to the news

Gainers

  • Ernexa Therapeutics (NASDAQ:ERNA) stock increased by 88.3% to $11.41 during Wednesday's pre-market session. The market value of their outstanding shares is at $7.0 million.
  • Catheter Precision (AMEX:VTAK) shares moved upwards by 20.94% to $0.68. The company's market cap stands at $2.0 million.
  • Lakewood-Amedex (NASDAQ:LABT) shares increased by 12.54% to $2.87. The market value of their outstanding shares is at $4.4 million.
  • BioCardia (NASDAQ:BCDA) shares increased by 12.21% to $0.9. The market value of their outstanding shares is at $11.9 million.
  • Autonomix Medical (NASDAQ:AMIX) stock rose 11.51% to $5.79. The company's market cap stands at $2.8 million.
  • Pomdoctor (NASDAQ:POM) shares increased by 10.41% to $1.59. The company's market cap stands at $171.6 million.

Losers

  • Cardiff Oncology (NASDAQ:CRDF) shares decreased by 35.1% to $0.85 during Wednesday's pre-market session. The company's market cap stands at $89.5 million.
  • NextCure (NASDAQ:NXTC) stock fell 21.13% to $5.19. The company's market cap stands at $26.7 million.
  • Basel Medical Group (NASDAQ:BMGL) stock declined by 20.0% to $6.5. The company's market cap stands at $12.7 million.
  • AEON Biopharma (AMEX:AEON) stock decreased by 14.29% to $0.31. The market value of their outstanding shares is at $9.3 million.
  • Alzamend Neuro (NASDAQ:ALZN) stock fell 14.05% to $1.04. The company's market cap stands at $4.6 million.
  • Shuttle Pharmaceuticals (NASDAQ:SHPH) shares decreased by 11.06% to $3.7. The market value of their outstanding shares is at $2.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending